ARCHIVES

DRCCA Board Fails To Agree on New Guidelines For Cancer Control Core Grants, Will Try Again

This article is from The Cancer Letter archive.

Vol. 07 No. 26 | June 25, 1981

Download PDF Visit The Full Archive

Related Articles

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

February 21, 2003

Growing Number Of New Research Ideas Create NCI Dilemma; How to Fund Them With A Flat Budget

October 1, 1982

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010